Verstovsek S, Gerds AT, Vannucchi AM, Al-Ali HK, et al. Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study. Lancet 2023;401:269-280.
PMID: 36709073